← FDA DRUG APPROVALS

FDA ANDA · ANDA070293

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: LYPHOMED

APPLICATION
ANDA070293
TYPE
ANDA
ORIGINAL APPROVAL
1986-01-24
LATEST ACTION
1990-06-04
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE/2ML · INJECTABLE · INJECTION

Approval history

1990-06-04Labeling · Supplement 15AP
1989-11-20Labeling · Supplement 11AP
1986-01-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →